# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-26-037458
Filing Date
2026-08-12
Accepted
2026-08-12 17:29:38
Documents
76
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 1215661
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 17470
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 17615
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 7801
5 | EX-32.2 | ex32-2.htm | EX-32.2 | 7724
| Complete submission text file | 0001493152-26-037458.txt |  | 7118943

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | cdt-20260630.xsd | EX-101.SCH | 59719
7 | XBRL CALCULATION FILE | cdt-20260630_cal.xml | EX-101.CAL | 69456
8 | XBRL DEFINITION FILE | cdt-20260630_def.xml | EX-101.DEF | 297456
9 | XBRL LABEL FILE | cdt-20260630_lab.xml | EX-101.LAB | 489324
10 | XBRL PRESENTATION FILE | cdt-20260630_pre.xml | EX-101.PRE | 398916
79 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 988458

Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CDT Equity Inc. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41245 | Film No.: 261268916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)